|
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 25, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced today the closing of its previously announced non-brokered private placement raising total gross proceeds of $450,000 (the "private placement"). The proceeds will be used by the Company to support development with DM199 for the treatment of stroke and vascular diseases and for other working capital purposes. |
